About MITRO

Company Profile

Management Team

Evolution

News

Annual Inspection of Jiangsu Province Laboratory Animal License

Annual Inspection of Jiangsu Province Laboratory Animal License

2025-01-23

Exhibition | Mitro will soon participate in the SNMMI 2024 Annual Meeting

Exhibition | Mitro will soon participate in the SNMMI 2024 Annual Meeting

2024-04-30

The 2024 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) will be held from June 8-11, 2024, in Toronto, Canada. The SNMMI Annual Meeting is recognized as the premier educational, scientific, research, and networking event in the field of nuclear medicine and molecular imaging, attracting thousands of professionals from around the world each year.

Annual Inspection of Jiangsu Province Laboratory Animal License

Annual Inspection of Jiangsu Province Laboratory Animal License

2024-03-20

Annual Inspection Report of Laboratory Animal License in Jiangsu Province

Radiopharmaceutical CRDMO MITRO Has Raised Nearly 400 Million Yuan to Support the Development of Innovative Drugs!

Radiopharmaceutical CRDMO MITRO Has Raised Nearly 400 Million Yuan to Support the Development of Innovative Drugs!

2024-03-18

On March 18, 2024, Yantai Dongcheng Pharmaceutical Group Co., Ltd. announced that it agreed to increase the capital and shares of its subsidiary MITRO (Yantai) Biotech Co., Ltd. (hereinafter referred to as "MITRO" or "the company"), which will be led by SDIC investment promotion, SDIC cohesion and Shandong local industrial fund, etc., with a total financing of nearly 400 million yuan.

Publicity on Declaring Postgraduate Workstation in Jiangsu Province in 2023

Publicity on Declaring Postgraduate Workstation in Jiangsu Province in 2023

2023-06-30

According to the spirit of the documents issued by Jiangsu Provincial Education Department and Jiangsu Provincial Science and Technology Department "Notice on Doing a Good Job in Applying for Jiangsu Postgraduate Workstation and Jiangsu Provincial Outstanding Postgraduate Workstation Demonstration Base in 2023" (Su Jiaoban Letter [2023] No. 5) and "Administrative Measures for Jiangsu Postgraduate Workstation", the two sides decided to jointly apply for Jiangsu Postgraduate Workstation in 2023 through negotiation between the company and Nanjing Medical University School of Pharmacy.

MITRO Acquires Xing Imaging LLC to Strengthen Clinical Accompanying Diagnosis and Nuclear Drug Imaging Service Capabilities!

MITRO Acquires Xing Imaging LLC to Strengthen Clinical Accompanying Diagnosis and Nuclear Drug Imaging Service Capabilities!

2022-12-12

On December 10, 2022, MITRO (Nanjing) Biotech Co., Ltd. announced that it would acquire Xing Imaging LLC, a nuclear drug conversion and clinical trial imaging CRO service company located in Delaware, USA, to assist international pharmaceutical companies in accurately diagnosing CRO services during clinical trials by using the preparation quality control technology of new PET drugs, PET scanning services and image reading management experience of new PET drugs.

< 123 >